Five things for pharma marketers to know: Thursday, November 16, 2017
Docs biased against research from poor countries, study finds; Astellas probed over patient-assistance charity support; Acorda reports deaths in Parkinson’s trial
Medical Journal
Physicians still rely on medical journals but turn to the web when they have only 10 minutes
Drugmakers can do a better job of organizing dosing information, safety information, and clinical data on their brand websites, a new survey found.
Five things for pharma marketers to know: Tuesday, September 13, 2016
Drugmakers routinely pay ghostwriters to write industry-funded research articles; Horizon to buy Raptor for $800 million; WellDoc partners with J&J
Which brands spent the most on professional ads in 2015?
Here are the brands and companies that advertised the most on professional ads in 2015.
When it comes to professional ads, print makes its comeback
Following print’s best year since 2011, it’s time to rewrite those journal-advertising obituaries. Medical-surgical print journal spending in 2015 was up 8.4% to $372 million.
Five things for pharma marketers to know: Thursday, September 17, 2015
New analysis says Paxil is not safe or effective for teens; some FDA reviewers voted against Addyi approval over side effects; HHS partners with AstraZeneca on antibiotic development
Elsevier sends wave of takedown requests
Elsevier is taking a hard-line posture against several different universities, asking them to take down scholarly research.
Japan investigates cancer “articles”
The Heath, Labor and Welfare ministry says a publisher passed off advertorials as articles.
Study reveals doc detail preferences: Hang up the phone
Doctors shared their information preferences with CMI/Compas, revealing ways marketers can better pace their communications to max out channels.
